Follow The Filings

LFCR Lifecore Biomedical Inc.

Health Care, filed as LIFECORE BIOMEDICAL INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 10.9%
  • $17M
  • 1 reduce

In 2026 Q2 Scott Miller trimmed Lifecore Biomedical.

Who owns this now

Largest portfolio weights among holders, up to 10.9% (Scott Miller, Greenhaven Road Investment Management). Not free-float ownership.

  1. Scott Miller Reduce 10.9%

Who owns LFCR

Sorted by value, long equity only, as of 2026 Q2.

History
Scott Miller, Greenhaven Road Investment Management 10.9% Reduce −9.8% 3,190,769 $17M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $103.27M $128.26M $128.87M
Gross profit $27.98M $41.85M $40.3M
Gross margin * 27.1% 32.6% 31.3%
Net income -$99.56M $12.01M -$38.72M
Net margin * -96.4% 9.4% -30.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $83.13M $81.03M $85.68M
Total non-current assets * $153.53M $172.93M $153.66M
Total assets $236.66M $253.96M $239.34M
Total current liabilities $37.4M $38.87M $30.18M
Total non-current liabilities * $125.7M $161.19M $161.73M
Total equity $35.02M $11.32M $1.34M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$17.44M -$0.217M -$0.206M
Cash from investing -$4.81M -$17.92M -$6.42M
Cash from financing $39.7M $7.51M $6.42M
Net change in cash $17.45M -$10.63M -$0.197M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.